National and Kapodistrian University of Athens
Επιδημιολογία των πρωτοπαθών όγκων του κεντρικού νευρικού συστήματος στην Ελλάδα
Abstract
dc:descriptionPrimary central nervous system (CNS) tumors comprise a heterogeneous group ofmalignancies. The epidemiology of these neoplasms is still considered inconclusiveand reports from countries with comparable epidemiological data reveal spatial andtemporal variations, which need to be further investigated.Following the completion of the first 5-year nationwide childhood registration inGreece, the quality of which follows the IARC criteria, patterns and temporal trendsof childhood CNS tumors are presented along with comparison to data from severalregional and national registries in the Region of Southern and Eastern Europe (SEE).In the absence of data for greek Adolescents and Young Adults (AYAs),epidemiological data of CNS tumors of this distinct age group in the SEE area wereexamined and comparisons with the publicly available US data from SEER wereundertaken.In Greece, for the first study period 2009-2014, the age-adjusted incidence rate ofmalignant childhood CNS tumors was 22.4 per million children, which wascomparable with the average incidence rate observed in the 12 participating SEERegistries (23 per million children). During the whole study period (1983-2014), aslight predominance of males was observed, and the incidence rates were declininggradually with the age. Astrocytomas were overall the most common subgroup (30%),followed by embryonal tumors. The latter was the predominant subgroup in sixregistries, including Greece. For the further evaluation of the observed bidirectionaltemporal trends and the various geographical disparities, factors affecting theregistration quality should be considered.Substantial variations in mortality and survival were observed among the 14 SEEparticipating registries. In most countries, mortality time trends were rather stable,except for Bulgaria, which demonstrated the highest rate during the initial registration period followed by a steadily decreasing annual mortality rate. A steep decrease insurvival was evident before the second year of follow-up. After adjusting fordiagnostic groups, age, gender and the year of diagnosis, Greece presented highersurvival compared to the other contributing countries, although the follow-up periodwas short. Irrespective of the country, rural residence was found to impose substantialadverse repercussions on survival.In the age group of AYAs, the overall age-adjusted incident rate of malignant CNStumors was significantly higher (28.1 per million) in SEE (11.438 cases for the period1990-2014) compared to SEER (24.7 per million, 13.573 cases for the period 1990-2012). Astrocytomas comprised almost half of the cases in both regions, albeit thehigher proportion of unspecified cases in SEE registries (30% versus 2.5% SEER).We observed similar age and gender distributions across SEE and SEER with a maleto female ratio of 1.3 and an overall increase of incidence by age. The observedincrease in incidence rates, documented in four SEE registries, namely GreaterPoland, Portugal North, Turkey-Izmir and Ukraine, could potentially be the result ofimprovements in registrations. Finally, a decreasing trend in Croatia (-2.5%), and arather stable rate in SEER (-0.3%) were noted.Mortality rates in SEE (range: 11.9-18.5 deaths per million) were higher overall thanthe SEER rate (9.4 deaths per million), with decreasing trends in both regions.Survival rates increased during a comparable period (2001-2009) in SEE and SEER.The 5-year survival rate was considerably lower in the SEE registries (46%) versusSEER (67%), mainly because of the extremely low rates of Ukraine; this finding wasconsistent across age groups and diagnostic subtypes. The highest 5-year survivalrates were recorded for ependymomas (76% SEE, 92% SEER), and the worst wererecorded for glioblastomas and anaplastic astrocytomas (28% SEE, 37% SEER).Advancing age, male sex, and rural residency at diagnosis adversely affectedoutcomes in both regions.In conclusion, epidemiological data on CNS tumors from the NARECHEM-ST andother registries in the SEE area are reported for the first time in this thesis. The resultsof the Greek registration are comparable with those reported by other developedEuropean countries, whereas the observed heterogeneity in registration practices andincidence rates of childhood CNS tumours across the SEE area necessitates furtherinvestigation. The cross-country mortality and survival variations possibly reflectsuboptimal levels of health care delivery and cancer control in some regions of SEE.Regarding the AYAs age group, the higher incidence rates of malignant CNS tumorsrecorded in the SEE area compared to the United States of America could be alsoexplained by possible environmental and/or genetic factors. The considerableoutcome discrepancies between some registries and the overall worse prognosis ofpatients residing in rural areas reflect inequalities in health care delivery. Albeit thecomplexity of the interpretation of temporal trends affected by registrationimprovements, no significant increase in incidence rates appears while survival ratesimprove with some time lag in the SEE area. The results of the thesis can contributeto an evidence-based health-care planning in order to diminish inequalities for adisease with an unfavorable outcome compared to other cancers affecting young agegroups.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papathoma, Paraskevi
- Παπαθωμά, Παρασκευή
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45163